Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-12-12, Stock:JNJ, The news for the past five days is as follows:
2019-12-05: NEWS1: /C O R R E C T I O N -- Johnson & Johnson/.NEWS2: Dow Jones Today: Trade Influenced Stocks More Than Impeachment News.NEWS3: 3M, Cisco share losses lead Dow's 75-point fall.NEWS4: J&J Stock Witnesses Volatility in '19: What to Expect in 2020.NEWS5: Abbott Is One Of The Biggest Medical Stocks — Should You Buy ABT Stock Now?.NEWS6: UPDATE 2-Half a million Ebola vaccine doses to be stockpiled for emergency use.
2019-12-06: NEWS1: 4 Health Care Stocks Gurus Broadly Own.NEWS2: Here's why Oregon rejected Johnson & Johnson's pelvic mesh settlement offer.NEWS3: Pharma Stock Roundup: FDA Updates for RHHBY, AZN, MRK, No Asbestos in Talc Says JNJ.NEWS4: Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV.
2019-12-09: NEWS1: J&J CEO Gorsky spurns U.S. congressional hearing on carcinogens in talc products.NEWS2: J&J CEO spurns U.S. congressional hearing on carcinogens in talc products.NEWS3: Johnson & Johnson Emerging Out Of A Dark Place.NEWS4: Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar.NEWS5: J&J Presents Data on CAR-T Therapy Drug and Imbruvica at ASH.NEWS6: Bluebird Bio Stock Is Rising on Promising Cancer-Drug Data.
2019-12-10: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results.NEWS3: Drug manufacturers have spent a record $342 billion on M&A in 2019.NEWS4: UPDATE 1-J&J CEO spurns U.S. congressional hearing on carcinogens in talc products.
2019-12-11: nan

Answer: Rise